New Heart Failure Pill Entresto Approved by FDA - http://clapway.com/2015/07/08/new-heart-failure-pill-entresto-approved-by-fda789/

Helping to Prevent Heart Failure

Many diseases or health complications are tough to deal with, but a healthy heart is essential to any human being’s long-term survival. That is why yesterday, the FDA approved a new medicinal pill called Entresto from Norvartis for treating heart failure. The announcement of the approval was released by both the FDA and Novartis yesterday, showing both parties’ eagerness in helping to reduce the threat of heart failure and the often ensuing death from heart complications.

A brief overview of heart failure

For those unfamiliar with heart failure and its history, heart complications happen when the heart is not pumping blood as well as it should, and there are not enough nutrients and oxygen reaching parts of your body. According to the CDC, every year in the U.S. alone, citizens die of heart disease complications often- every 1 in 4 deaths. In the news release by the FDA, the number of people stated to be affected by heart failure is a whopping 5.1 million people in the U.S. There is no cure for this complication, but you can live with it. This is where our drug, Entresto, comes into play.

What is Entresto?

Entresto is said to be a neprilysin inhibitor and angiotensin II receptor blocker that will help to reduce of the risk of dying from heart failure, and also allow for fewer trips to the hospital. The pills are to be taken twice a day along with other heart failure meds you may be prescribed, but it is advised against taking the drug when you have had Angiodema. It is also advised not to take Entresto if you start suffering from this allergic reaction while taking the drug, because breathing becomes difficult as a result.

But this is not the only side effect of taking Entresto; there are other complications that arise when taking the pill. Some of the side effects include hypertension, kidney problems, etc.

Good Intentions from Entresto

The reduction rate of death and hospitalization when using the drug is around twenty percent. With the approval of the new medication, the 5.1 million afflicted with heart failure, as reported by the FDA, now have hope of living better as a result. Now that it is approved in the U.S., the drug is now being reviewed in other countries for approval. Then, subsequent distribution is expected to follow after approval.

---

 

Hate getting that jolt in your heart from your annoying morning alarm? The future is here- the Sensorwake olfactory alarm clock, 99% effective at waking you up with your favorite smells alone.

New Heart Failure Pill Entresto Approved by FDA

New Drug for Cystic Fibrosis Approved by FDA - http://clapway.com/2015/07/03/new-drug-for-cystic-fibrosis-approved-by-fda765/

New Drug for Cystic Fibrosis approved by FDA

Yesterday, the FDA announced its approval of the new drug to treat those who have the F509del mutation of Cystic Fibrosis. The announcement can be found on their website, in which the post about the new drug for Cystic Fibrosis was put up for immediate release.

What is the new drug for Cystic Fibrosis?

The new drug is called Orkambi that is a combination therapy to treat CF, featuring the chemicals ivacaftor and lumcaftor. The new drug for Cystic Fibrosis is supposed to help correct the mutated genes in the afflicted whereas before efforts were concentrated on treating the symptoms of CF.

Drug cut through some tedious wait time.

In addition to being approved by the FDA, the new drug was given the drug designation of “orphan drug” for its treatment of CF, which brings many benefits to the developers of the drug. Among those benefits are financial incentives, and other promotional deals to produce the drug. The drug has cut through some longer trial testing in the priority review of six months or so instead of the usual ten month trail because the new drug for Cystic Fibrosis is supposed to be a huge game changer.

The clinical trials had positive results which helped in the drug getting its approval by the FDA. In fact, in the study those who took two of the new drug for Cystic Fibrosis every twelve hours showed having better lung function than those who were taking the placebo.

However, the new drug for Cystic Fibrosis is not without its drawbacks as well. The common side effects of the drug in the news release are shortness of breath, upper respiratory tract infection, nausea, diarrhea, and rash that can pop up. Some women who took the drug even experienced increased menstrual bleeding and a few other things.

But there is also the fact that the drug is targeted only to a specific genetic mutation and not the disease as a whole, although some help is better than no help at all in aiding those afflicted with CF.

---

 

Stay healthy, hydrated, and fit with the HidrateMe water bottle.

New Drug for Cystic Fibrosis Approved by FDA